From: The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Demographics | |
Age | |
Gender | |
Years of education | |
Clinical information | |
Diagnosis | |
Medication use | |
Cardiovascular medication | |
Dementia medication | |
Hormonal medication | |
Psychopharmaceuticals | |
Other medication | |
Comorbidities | |
Cardiovascular disorders | |
Cardiovascular risk factors | |
Cerebrovascular disorders | |
Endocrine disorders | |
Neurological disorders | |
Other cardiac disorders | |
Psychiatric disorders | |
Somatic disorders | |
Family history of dementia | |
First-degree relatives | |
Second-degree relatives | |
Functional impairment rating | |
Neuropsychological tests | |
Memory, preferred test: AVLT | |
Language, preferred test: animal fluency | |
Attention, preferred test: Trail Making Test A | |
Executive functioning, preferred test: Trail Making Test B | |
Visuoconstruction, preferred test: Rey complex figure copy | |
Aβ measure a | |
CSF Aβ42 value and local cutoff point | |
Amyloid PET SUV and local cutoff point |